ARROWHEAD PHARMACEUTICALS, INC. Insider Trading for February 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARROWHEAD PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARROWHEAD PHARMACEUTICALS, INC. for February 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | M | 2.01 | 42,500 | 85,425 | 392,500 | |
| Feb 27 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 18.98 | 42,500 | 806,650 | 644,606 | 687.1 K to 644.6 K (-6.19 %) |
| Feb 27 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Buy | M | 2.01 | 42,500 | 85,425 | 687,106 | 644.6 K to 687.1 K (+6.59 %) |
| Feb 26 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Option Exercise | M | 4.75 | 7,000 | 33,250 | 0 | |
| Feb 26 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Option Exercise | M | 2.62 | 10,000 | 26,200 | 7,000 | |
| Feb 26 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Option Exercise | M | 2.19 | 18,000 | 39,420 | 17,000 | |
| Feb 26 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Option Exercise | M | 5.19 | 30,000 | 155,700 | 35,000 | |
| Feb 26 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Sell | S | 19.25 | 65,000 | 1,251,250 | 175,130 | 240.1 K to 175.1 K (-27.07 %) |
| Feb 26 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Buy | M | 4.75 | 7,000 | 33,250 | 240,130 | 233.1 K to 240.1 K (+3.00 %) |
| Feb 26 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Buy | M | 2.62 | 10,000 | 26,200 | 233,130 | 223.1 K to 233.1 K (+4.48 %) |
| Feb 26 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Buy | M | 2.19 | 18,000 | 39,420 | 223,130 | 205.1 K to 223.1 K (+8.77 %) |
| Feb 26 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Buy | M | 5.19 | 30,000 | 155,700 | 205,130 | 175.1 K to 205.1 K (+17.13 %) |
| Feb 26 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Sell | S | 18.05 | 3,000 | 54,150 | 175,130 | 178.1 K to 175.1 K (-1.68 %) |
| Feb 20 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Option Exercise | M | 5.20 | 8,000 | 41,600 | 235,000 | |
| Feb 20 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 18.00 | 8,000 | 144,000 | 305,607 | 313.6 K to 305.6 K (-2.55 %) |
| Feb 20 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Buy | M | 5.20 | 8,000 | 41,600 | 313,607 | 305.6 K to 313.6 K (+2.62 %) |
| Feb 20 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | M | 2.01 | 42,500 | 85,425 | 435,000 | |
| Feb 20 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 17.98 | 42,500 | 764,150 | 644,606 | 687.1 K to 644.6 K (-6.19 %) |
| Feb 20 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Buy | M | 2.01 | 42,500 | 85,425 | 687,106 | 644.6 K to 687.1 K (+6.59 %) |
| Feb 20 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 17.67 | 26,250 | 463,838 | 644,606 | 670.9 K to 644.6 K (-3.91 %) |
| Feb 12 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | M | 2.01 | 42,500 | 85,425 | 477,500 | |
| Feb 12 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | M | 2.62 | 11,667 | 30,568 | 520,000 | |
| Feb 12 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | M | 2.62 | 11,667 | 30,568 | 531,667 | |
| Feb 12 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 17.06 | 42,500 | 725,050 | 670,856 | 713.4 K to 670.9 K (-5.96 %) |
| Feb 12 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Buy | M | 2.01 | 42,500 | 85,425 | 713,356 | 670.9 K to 713.4 K (+6.34 %) |
| Feb 12 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 16.48 | 57,000 | 939,360 | 670,856 | 727.9 K to 670.9 K (-7.83 %) |
| Feb 12 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 15.66 | 97,167 | 1,521,635 | 727,856 | 825 K to 727.9 K (-11.78 %) |
| Feb 12 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Buy | M | 2.62 | 11,667 | 30,568 | 825,023 | 813.4 K to 825 K (+1.43 %) |
| Feb 12 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 15.34 | 46,167 | 708,202 | 813,356 | 859.5 K to 813.4 K (-5.37 %) |
| Feb 12 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Buy | M | 2.62 | 11,667 | 30,568 | 859,523 | 847.9 K to 859.5 K (+1.38 %) |
| Feb 07 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 14.48 | 22,500 | 325,800 | 847,856 | 870.4 K to 847.9 K (-2.59 %) |
| Feb 01 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 13.85 | 28,500 | 394,725 | 870,356 | 898.9 K to 870.4 K (-3.17 %) |